PANACEA LIFE SCIENCES HOLDINGS, INC. Cash Flow Statement
PLSH|10 years of annual SEC 10-K data (FY2014-FY2023)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 10 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$2M
FY2023
Free Cash Flow
-$2M
FY2023
Capital Expenditures
$65,322
Cash used for long-term assets
Dividends Paid
N/A
FY2023
PANACEA LIFE SCIENCES HOLDINGS, INC. used $2M in operating cash flow and negative free cash flow of $2M in FY2023.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$8.0M | -$9.1M | -$4.8M | -$5.2M | -$4.5M | -$4.3M | -$3.9M | -$1.6M | -$358.0K | -$296.6K |
| Depreciation & Amortization | $1.7M | $1.7M | - | - | - | - | - | $0 | $1.6K | $1.8K |
| Operating Cash Flow | -$1.5M | -$2.4M | -$3.9M | -$7.6M | -$5.7M | -$465.8K | -$1.2M | -$891.0K | -$640.0K | -$399.6K |
| Capital Expenditures | $65.3K | $243.8K | $162.9K | $3.2M | $541.2K | $0 | - | -$1.3K | $0 | $6.0K |
| Free Cash Flow | -$1.6M | -$2.6M | -$4.1M | -$10.8M | -$6.3M | -$465.8K | - | -$889.7K | -$640.0K | -$405.7K |
| FCF Margin | -66.7% | -162.5% | -198.3% | -120.3% | -2913.4% | - | - | - | -300478.9% | -47613.6% |